The University of California at San Francisco Diabetes Research Center (DRC) functions as a basic and clinical research enterprise at the forefront of diabetes research. The DRC crosses the boundaries of Departments and Schools to support a highly interactive team investigating Type 1 and Type 2 diabetes to advance the understanding and treatment of the disease. The DRC integrates the research activities of the UCSF Diabetes Center, the administrative home of the DRC, with a broader range of diabetes-focused research throughout UCSF. The combined intellectual and research expertise of the DRC encompasses 66 diabetes investigators from 26 departments and organized research units, 3 schools, and six campuses focused on both basic and clinical research, supported with $56,455,025 annual direct costs in diabetes- related grant funding, including $36,070,247 in NIH funding. In this application, we propose to continue the success of the UCSF DRC in promoting, enhancing and integrating diabetes research at UCSF. That goal is realized through support for the following activities: An Administrative Core provides leadership, infrastructure, administrative support, advice and oversight to the other components and members of the DRC, regularly adapts Cores and Programs to fit the needs of the members, and interfaces with the NIDDK, other NIH Diabetes Centers, and the lay community. Biomedical Research Cores: Islet Production Core: Provides mouse and human islets together with expertise, advice and training. Regional Islet Core: Extends the resources of the Islet Core to N. California, Oregon and Washington. Flow Cytometry & Cell Sorting Core: Provides equipment, assistance and training for human and animal cell analysis. Microscopy Core: Provides advanced imaging equipment, technologies, advice and training. Mouse Metabolism Core: Provides the specialized cages, equipment and assistance for mouse metabolic studies. Genetic Modification Core: Provides genome editing, vectors, and transgenic and knock-out mice. A Pilot & Feasibility Program that funds small innovative projects that support new investigators, attract new investigators to diabetes and the DRC, explore new questions by established investigators, promote interactions and lead to external funding support to further the goals of the DRC. An Enrichment Program that supports DRC members and the regional diabetes research community by enhancing scientific exchange and training with seminar series, invited speakers, and an annual retreat.

Public Health Relevance

The UCSF Diabetes Research Center (DRC) provides facilities and resources that enhance collaborations and expand the scope of diabetes research throughout UCSF. As a consequence of the interactions cultivated by the DRC, the intellectual and scientific value of diabetes-focused research at UCSF will continue to be magnified beyond the >$55M in direct research funds currently received annually for diabetes-related studies by UCSF the 66 DRC members.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK063720-13
Application #
9274288
Study Section
Special Emphasis Panel (ZDK1-GRB-S (J4)P)
Program Officer
Hyde, James F
Project Start
2002-09-01
Project End
2020-03-31
Budget Start
2017-04-01
Budget End
2018-03-31
Support Year
13
Fiscal Year
2017
Total Cost
$1,496,377
Indirect Cost
$552,290
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94118
Mocciaro, Annamaria; Roth, Theodore L; Bennett, Hayley M et al. (2018) Light-activated cell identification and sorting (LACIS) for selection of edited clones on a nanofluidic device. Commun Biol 1:41
Miranda, Diego A; Krause, William C; Cazenave-Gassiot, Amaury et al. (2018) LRH-1 regulates hepatic lipid homeostasis and maintains arachidonoyl phospholipid pools critical for phospholipid diversity. JCI Insight 3:
Greenstein, R A; Jones, Stephen K; Spivey, Eric C et al. (2018) Noncoding RNA-nucleated heterochromatin spreading is intrinsically labile and requires accessory elements for epigenetic stability. Elife 7:
Chamberlain, Chester E; German, Michael S; Yang, Katherine et al. (2018) A Patient-derived Xenograft Model of Pancreatic Neuroendocrine Tumors Identifies Sapanisertib as a Possible New Treatment for Everolimus-resistant Tumors. Mol Cancer Ther 17:2702-2709
Lee, Jessica; Pappalardo, Zachary; Chopra, Deeksha Gambhir et al. (2018) A Genetic Interaction Map of Insulin Production Identifies Mfi as an Inhibitor of Mitochondrial Fission. Endocrinology 159:3321-3330
Sneddon, Julie B; Tang, Qizhi; Stock, Peter et al. (2018) Stem Cell Therapies for Treating Diabetes: Progress and Remaining Challenges. Cell Stem Cell 22:810-823
Siljee, Jacqueline E; Wang, Yi; Bernard, Adelaide A et al. (2018) Subcellular localization of MC4R with ADCY3 at neuronal primary cilia underlies a common pathway for genetic predisposition to obesity. Nat Genet 50:180-185
Hennings, Thomas G; Chopra, Deeksha G; DeLeon, Elizabeth R et al. (2018) In Vivo Deletion of ?-Cell Drp1 Impairs Insulin Secretion Without Affecting Islet Oxygen Consumption. Endocrinology 159:3245-3256
Roth, Theodore L; Puig-Saus, Cristina; Yu, Ruby et al. (2018) Reprogramming human T cell function and specificity with non-viral genome targeting. Nature 559:405-409
Hirano, Arisa; Hsu, Pei-Ken; Zhang, Luoying et al. (2018) DEC2 modulates orexin expression and regulates sleep. Proc Natl Acad Sci U S A 115:3434-3439

Showing the most recent 10 out of 531 publications